375 related articles for article (PubMed ID: 21690631)
1. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
Myers CA; Faix DJ; Blair PJ
Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
[No Abstract] [Full Text] [Related]
2. Using surveillance to evaluate influenza vaccine effectiveness.
Jackson LA
J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
[No Abstract] [Full Text] [Related]
3. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
4. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Mallory RM; Yi T; Ambrose CS
Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
[TBL] [Abstract][Full Text] [Related]
5. [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2209-14. PubMed ID: 17061434
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
7. Update: influenza activity--United States, October 2-November 26, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(48):1646-9. PubMed ID: 22157883
[TBL] [Abstract][Full Text] [Related]
8. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
[TBL] [Abstract][Full Text] [Related]
9. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
[TBL] [Abstract][Full Text] [Related]
10. Etiology of influenza viruses isolated in Russia from 1998 up to present time.
Konovalova NI; Litvinova OM; Gudkova TM; Lobova TG; Grigorieva VA; Eropkin MU; Yaglovskaya IB
Vaccine; 2006 Nov; 24(44-46):6697-700. PubMed ID: 16920234
[TBL] [Abstract][Full Text] [Related]
11. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
Valenciano M; Kissling E;
Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
[TBL] [Abstract][Full Text] [Related]
12. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
[TBL] [Abstract][Full Text] [Related]
13. Update: influenza activity--United States and worldwide, May 22-September 3, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(36):1239-42. PubMed ID: 21918493
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
[TBL] [Abstract][Full Text] [Related]
15. Update: influenza activity --- United States, October 3-December 11, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Dec; 59(50):1651-5. PubMed ID: 21178950
[TBL] [Abstract][Full Text] [Related]
16. Seasonal trivalent influenza vaccine for 2010-2011.
Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
[No Abstract] [Full Text] [Related]
17. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.
Huber VC; McCullers JA
J Infect Dis; 2006 Mar; 193(5):677-84. PubMed ID: 16453263
[TBL] [Abstract][Full Text] [Related]
18. Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing.
Ambrose CS
Hum Vaccin Immunother; 2012 Feb; 8(2):279; author reply 280. PubMed ID: 22426366
[No Abstract] [Full Text] [Related]
19. Update: influenza activity--United States, October 3, 2010-February 5, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(6):175-81. PubMed ID: 21330967
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of influenza vaccines.
Linder J
N Engl J Med; 2010 Jan; 362(2):180; author reply 180-1. PubMed ID: 20077593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
